Sulfinpyrazone decreases epinephrine-induced platelet aggregation after myocardial infarction
- 30 November 1982
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 50 (5) , 938-944
- https://doi.org/10.1016/0002-9149(82)90399-x
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Favorable effect of sulfinpyrazone on thromboembolism in patients with rheumatic heart disease.Circulation, 1980
- Platelet survival time and thromboembolism in patients with mitral valve prolapse.Circulation, 1979
- Pathogenesis of Arterial Vascular DiseaseSeminars in Thrombosis and Hemostasis, 1979
- The effect of sulphinpyrazone on the aggregation and release reactions of human plateletsThrombosis Research, 1979
- A Controlled Study of the Effect of Sulfinpyrazone on Platelet Survival and on Platelet-Bound 14C-Serotonin Release in Patients with Previous Myocardial InfarctionActa Haematologica, 1979
- Inhibition of platelet adhesion to rabbit aorta by sulphinpyrazone and acetylsalicylic acidAtherosclerosis, 1977
- Effects of clofibrate and sulfinpyrazone on platelet survival time in coronary artery disease.Circulation, 1975
- Platelet Survival and Adhesiveness in Recurrent Venous ThrombosisNew England Journal of Medicine, 1973
- Altered Platelet Function in Patients with Prosthetic Mitral Valves Effects of Sulfinpyrazone TherapyCirculation, 1970
- ALTERATION OF THE RESPONSE OF PLATELETS TO SURFACE STIMULI BY PYRAZOLE COMPOUNDSThe Journal of Experimental Medicine, 1967